You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:創業板指跌2%,醫療醫藥板塊集體撲街
格隆匯 11-17 15:41

今日,滬深兩市主要指數下跌,滬指全天收跌0.21%報3339.9點,深成指跌0.85%報13732.52點,創業板指跌2%報2658.09點;兩市總成交逾8500億元,北上資金呈小幅淨買入狀態。

盤面上,市場情緒低迷,板塊輪動加劇,此前大漲的有色板塊回落,主力資金流向港口航運、銀行、地產板塊。整體看,航運概念漲幅最大,中遠海控等多股漲停;銀行股近乎全線上漲,寧波銀行漲5%;交通設施、地產板塊漲幅靠前;汽車板塊早間衝高後持續回落,白酒股尾盤跳水,半導體板塊午後走強。醫療、電器儀表、醫藥等板塊大跌靠前。

醫療保健板塊大幅暴跌。其中,通策醫療重挫8%,英科醫療跌7.63%,正川股份、戴維醫療均跌超6%,英特集團、海爾生物、振德醫療均跌超5%,愛爾眼科、藍帆醫療等跌超4%。另值得注意的是,邁瑞醫療重挫3.42%,最近9個交易日累計下跌16.4%。

生物製藥板塊也集中重挫。其中,智飛生物重挫11.37%,西藏藥業跌8.26%,復星醫藥跌7.6%,康泰生物、達安基因跌超5%,藥明康德、康希諾、愛美客均跌超3%。

海運概念則逆勢大幅走強。其中,中遠海特、中遠海控、中遠海發、寧波海運均強勢漲停,中遠海能、渤海輪渡、招商輪船等紛紛大漲。

消息面上,11月15日,東盟十國以及韓國、日本、澳大利亞、新西蘭、中國正式簽署“區域全面經濟夥伴關係協定”(RCEP)。根據協議,各成員之間關税減讓以立即降至零關税、十年內降至零關税的承諾為主,而中國和日本首次達成了雙邊關税減讓安排,實現了歷史性突破。

房地產板塊表現強勢。其中,我愛我家、榮安地產、京漢股份漲停,中南建設、金科股份均大漲超3%,金地集團、華夏幸福大漲4%。

銀行股表現造好。其中,寧波銀行大漲5%,杭州銀行大漲3%,平安銀行、成都銀行、廈門銀行均大漲超2%,招商銀行、興業銀行等漲超1%。其中,招商銀行從7月以來已經累計上漲34%。

科創板方面,195家上市企業,147家企業下跌。其中,西部超導、固德威均跌超7%,碩世生物、奕瑞科技跌超6%,盟升電子、海爾生物、東方生物均跌超5%。另外,利揚芯片、阿拉丁均大漲超16%,鉑力特大漲8%。

北向資金全天單邊淨流入5333萬元,其中滬股通淨流入15.31億元, 深股通淨流出14.78億元。其中,上午盤中一度淨流出25億元左右。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account